DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Khalaf DJ, Annala M, Taavitsainen S. et al.
Optimale sequencing of enzalutamide and abiraterone plus prednisone in metastatic castration-resistant prostate cancer: a multi-centre randomised open-label phase 2 crossover trial.
Lancet Oncol 2019;
20: 1730-1739
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.